5AM Ventures Sells 400,000 Shares in Block Trade, Trims Camp4 Stake
CAMP has more than doubled off its 52-week low of $1.41.
Summary
5AM Ventures VI sold a 400,000-share block at $4.04 on August 27, 2026, plus 191,875 shares in open market sales, reducing its Camp4 Therapeutics stake amid a broader insider distribution pattern.
Key Events · Ownership and Investor Activity · CAMP
-
400,000-Share Block Sale
On August 27, 2026, 5AM Ventures VI sold 400,000 shares at $4.04 per share, generating approximately $1.62 million in proceeds.
-
Additional Open Market Sales
Between August 19-24, Ventures VI also sold 191,875 shares at prices ranging from $4.50 to $5.00 per share.
-
Insider Distribution Pattern
These sales follow director Andrew Schwab's $879,719 sale earlier in August and come after Camp4's $50.1 million private placement and resale registration of 32.7 million shares.
-
Beneficial Ownership at 9.9%
Andrew Schwab and Kush Parmar each report beneficial ownership of approximately 9.9% of Camp4's common stock, with the Pre-Funded Warrants subject to a 9.99% beneficial ownership blocker.
Analysis · CAMP · Life Sciences
A 400,000-share block was sold by 5AM Ventures VI, L.P. at $4.04 on August 27, 2026, alongside additional open market sales totaling 191,875 shares between August 19-24. The block sale alone represents roughly $1.62 million in proceeds and reduces the venture fund's stake in Camp4 Therapeutics. This follows a pattern of insider distribution: director Andrew Schwab sold $879,719 worth of stock earlier in August, and the fund's total beneficial ownership now stands at 9.9% for Schwab and Parmar. The sales come just weeks after Camp4 completed a $50.1 million private placement and registered 32.7 million shares for resale, suggesting the venture investors are actively monetizing their position as the stock trades near $4.
How filings like this one have moved
In the 30 days to Sep 13, 2026, 29.5% of the 1672 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.22%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CAMP was trading at $3.96 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $248.5M. The 52-week trading range was $1.41 to $7.75. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.